Nabumetone
  
Side effects 
	
		
Options: 
			
			Show MedDRA Preferred Terms
		
	
	
| Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 
| Diarrhoea | 14% |  | x | x | x | x | x | x | x | x | x | 
| Dyspepsia | 13% |  | x | x | x | x | x | x | x | x | x | 
| Abdominal pain | 12% |  | x | x | x | x | x | x | x | x | x | 
| Nausea | 9% |  |  | x | x | x | x | x | x | x | x | 
| Headache | 8% |  |  | x | x | x | x | x | x | x | x | 
| Rash | 7% |  |  | x | x | x | x | x | x | x | x | 
| Dizziness | 6% |  |  | x | x | x | x | x | x | x | x | 
| Flatulence | 6% |  |  | x | x | x | x | x | x | x | x | 
| Constipation | 4% |  |  | x | x | x | x | x | x | x | x | 
| Pruritus | 4% |  |  | x | x | x | x | x | x | x | x | 
| Tinnitus | 4% |  |  | x | x | x | x | x | x | x | x | 
| Insomnia | 3% |  | x | x | x | x | x | x | x | x | x | 
| Fatigue | 2% |  | x | x | x | x | x | x | x | x | x | 
| Dry mouth | 2% |  | x | x | x | x | x | x | x | x | x | 
| Faecal occult blood positive | 2% |  |  | x | x | x | x | x | x | x | x | 
| Somnolence | 2% |  | x | x | x | x | x | x | x | x | x | 
| Abnormal vision | 2% |  | x | x | x | x | x | x | x | x | x | 
| Dyspnoea | 1% |  | x | x | x | x | x | x | x | x | x | 
| Gastritis | 1% |  | x | x | x | x | x | x | x | x | x | 
| Melaena | 1% |  | x | x | x | x | x | x | x | x | x | 
| Nervousness | 1% |  | x | x | x | x | x | x | x | x | x | 
| Vomiting | 1% |  | x | x | x | x | x | x | x | x | x | 
| Sweating increased | 1% |  | x | x | x | x | x | x | x | x | x | 
| Depression | 0.9% |  |  |  |  |  |  |  |  |  | x | 
| Vertigo | 0.9% |  | x | x | x | x | x | x | x | x | x | 
| Paraesthesia | 0.8% |  | x | x | x | x | x | x | x | x | x | 
| Malaise | 0.8% |  | x | x | x | x | x | x | x | x | x | 
| Anorexia | 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Asthenia | 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Oedema | 0.7% |  |  | x | x | x | x | x | x | x | x | 
| Gastroenteritis | 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Urticaria | 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Weight increased | 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Albuminuria | 0.5% |  | x | x | x | x | x | x | x | x | x | 
| Anxiety | 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Duodenal ulcer | 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Gastric ulcer | 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Stomatitis | 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Confusional state | 0.3% |  | x | x | x | x | x | x | x | x | x | 
| Dysphagia | 0.3% |  | x | x | x | x | x | x | x | x | x | 
| Thrombocytopenia | 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Increased appetite | 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Bullous eruption | 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Photosensitivity | 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Gastrointestinal haemorrhage | 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Tremor | 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Vasculitis | 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Agitation | 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Azotaemia | 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Hyperuricaemia | 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Agranulocytosis | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Alopecia | postmarketing, 0.9% |  | x | x | x | x | x | x | x | x | x | 
| Anaemia | postmarketing, 0.5% |  | x | x | x | x | x | x | x | x | x | 
| Angina pectoris | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Arrhythmia | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Asthma | postmarketing, 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Cough | postmarketing, 0.6% |  | x | x | x | x | x | x | x | x | x | 
| Duodenitis | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Dysuria | postmarketing, 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Eructation | postmarketing, 0.7% |  | x | x | x | x | x | x | x | x | x | 
| Body temperature increased | postmarketing, 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Gingivitis | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Glossitis | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Haematuria | postmarketing, 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Hyperglycaemia | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Hypertension | postmarketing, 1.7% |  | x | x | x | x | x | x | x | x | x | 
| Hypokalaemia | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Calculus of kidney | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Leukopenia | postmarketing, 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Myocardial infarction | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Nightmare | postmarketing, 0.01% |  | x | x | x | x | x | x | x | x | x | 
| Palpitations | postmarketing, 1% |  | x | x | x | x | x | x | x | x | x | 
| Pancreatitis | postmarketing, 0.1% |  | x | x | x | x | x | x | x | x | x | 
| Syncope | postmarketing, 0.3% |  | x | x | x | x | x | x | x | x | x | 
| Taste disorders | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Thrombophlebitis | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Weight decreased | postmarketing, 0.4% |  | x | x | x | x | x | x | x | x | x | 
| Chills | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Erectile dysfunction | postmarketing, 0.2% |  | x | x | x | x | x | x | x | x | x | 
| Rectal haemorrhage | postmarketing, 0.5% |  | x | x | x | x | x | x | x | x | x | 
| Acne | postmarketing |  | x | x | x |  |  | x | x | x |  | 
| Anaphylactic shock | 0.01% |  | x | x | x | x | x | x | x | x | x | 
| Angioedema | 0.01% |  | x | x | x | x | x | x | x | x | x | 
| Anaphylactoid reaction | 0.01% |  | x | x | x | x | x | x | x | x | x | 
| Congenital anomaly |  |  |  |  |  |  |  |  |  | x |  | 
| Alveolitis allergic |  |  | x | x | x | x | x | x | x | x | x | 
| Aplastic anaemia |  |  |  |  |  |  |  |  |  |  | x | 
| Toxic epidermal necrolysis |  |  | x | x | x | x | x | x | x | x | x | 
| Erythema multiforme |  |  | x | x | x | x | x | x | x | x | x | 
| Haemorrhage |  |  |  |  |  |  |  |  |  |  | x | 
| Hypersensitivity |  |  | x | x | x |  | x | x | x | x | x | 
| Jaundice |  |  | x | x | x | x | x | x | x | x | x | 
| Jaundice cholestatic |  |  |  |  |  |  |  |  |  |  | x | 
| Nephritis interstitial |  |  | x | x | x | x | x | x | x | x | x | 
| Nephrotic syndrome |  |  | x | x |  | x | x | x | x | x | x | 
| Peptic ulcer |  |  |  |  |  |  |  |  |  |  | x | 
| Pneumonia |  |  |  | x |  |  |  |  |  |  |  | 
| Renal failure |  |  | x | x | x | x | x | x | x | x | x | 
| Stevens-Johnson syndrome |  |  | x | x | x | x | x | x | x | x | x | 
| Hepatic failure |  |  | x | x | x | x | x | x | x | x | x | 
| Interstitial pneumonia |  |  | x |  | x | x | x | x | x | x | x | 
| Nephritic syndrome |  |  |  |  | x |  |  |  |  |  |  | 
| Pseudoporphyria |  |  | x | x | x | x | x | x | x | x | x | 
| Raised liver function tests |  |  |  |  |  |  |  |  |  |  | x | 
| Eosinophilic pneumonia |  |  | x | x | x | x | x | x | x | x | x | 
| Vaginal haemorrhage |  |  | x | x | x | x | x | x | x | x | x | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 87 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 97 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 97 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 95 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 96 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 97 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 97 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 98 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 102 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |